Status: current, Defined. Date: 28-Feb 2021. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4527111000168114 | L.C.E. 125/31.25/200 (carbidopa 31.25 mg + entacapone 200 mg + levodopa 125 mg) tablet, 30 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4527121000168119 | L.C.E. 125/31.25/200 tablet, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
L.C.E. 125/31.25/200 tablet, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
L.C.E. 125/31.25/200 tablet, 30 | Is a | levodopa 125 mg + carbidopa 31.25 mg + entacapone 200 mg tablet, 30 | true | Inferred relationship | Some | ||
L.C.E. 125/31.25/200 tablet, 30 | has TP | L.C.E. 125/31.25/200 | true | Inferred relationship | Some | ||
L.C.E. 125/31.25/200 tablet, 30 | has TPUU | L.C.E. 125/31.25/200 tablet | true | Inferred relationship | Some | 1977388147 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
L.C.E. 125/31.25/200 tablet, 30, bottle | Is a | True | L.C.E. 125/31.25/200 tablet, 30 | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
Trade product pack reference set